An optimized workflow for CRISPR-Cas9 deletion of surface and intracellular factors in primary human T lymphocytes.
PLoS One
; 16(2): e0247232, 2021.
Article
in En
| MEDLINE
| ID: mdl-33600503
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Transcription Factors
/
CRISPR-Cas Systems
/
Gene Editing
/
Membrane Proteins
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
PLoS One
Year:
2021
Document type:
Article